Biodegradable Β‐cyclodextrin Conjugated Gelatin Methacryloyl Microneedle for Delivery of Water‐Insoluble Drug
Xingwu Zhou,Zhimin Luo,Avijit Baidya,Han-jun Kim,Canran Wang,Xing Jiang,Moyuan Qu,Jixiang Zhu,Li Ren,Fereshteh Vajhadin,Peyton Tebon,Niyuan Zhang,Yumeng Xue,Yudi Feng,Chengbin Xue,Yi Chen,KangJu Lee,Junmin Lee,Shiming Zhang,Chun Xu,Nureddin Ashammakhi,Samad Ahadian,Mehmet Remzi Dokmeci,Zhen Gu,Wujin Sun,Ali Khademhosseini
DOI: https://doi.org/10.1002/adhm.202000527
IF: 10
2020-01-01
Advanced Healthcare Materials
Abstract:Transdermal delivery of water-insoluble drugs via hydrogel-based microneedle (MN) arrays is crucial for improving their therapeutic efficacies. However, direct loading of water-insoluble drug into hydrophilic matrices remains challenging. Here, a biodegradable MN array patch that is fabricated from naturally derived polymer conjugates of gelatin methacryloyl and beta-cyclodextrin (GelMA-beta-CD) is reported. When curcumin, an unstable and water-insoluble anticancer drug, is loaded as a model drug, its stability and solubility are improved due to the formation of an inclusion complex. The polymer-drug complex GelMA-beta-CD/CUR can be formulated into MN arrays with sufficient mechanical strength for skin penetration and tunable drug release profile. Anticancer efficacy of released curcumin is observed in three-dimensional B16F10 melanoma models. The GelMA-beta-CD/CUR MN exhibits relatively higher therapeutic efficacy through more localized and deeper penetrated manner compared with a control nontransdermal patch. In vivo studies also verify biocompatibility and degradability of the GelMA-beta-CD MN arrays patch.